## ALRIB: MBE Duopoly + SiPho Supply Chain Play ### Overview **Bull Thesis**: $ALRIB (ALAB) leads Molecular Beam Epitaxy (MBE) equipment duopoly (~w/ $RIB.PA), enabling quantum dot lasers and silicon photonics for $MSFT Quantum + foundries like $IQE. Profitable, dividends, SiPho tool breakthroughs, accelerating orders = compelling vs $LWLG at current prices. **Position**: Upstream moat with financial edge over speculative downstream plays. ### Key Dynamics - **MBE Monopoly**: Critical for high-performance epitaxy (QD lasers, PICs). - **Supply Chain**: MBE → Epiwafers ($IQE) → Lasers → SiPho modules → $MSFT datacenters. - **Financial Superiority**: Cashflow positive + dividends vs $LWLG volatility. ### Validation Financials: Profitable (vs peers), backlog growth signals demand. ### Companies | Company | Role | Notes | |---------|------|-------| | $ALRIB | MBE Leader | Duopoly moat | | $RIB.PA | Duopoly Peer | Validates market | | $IQE | Epi Customer | Downstream pull | | $LWLG | Downstream Spec | Comparison | ### Risks - Customer concentration ($MSFT). - Capex cycle downturn. ### Catalysts - Order backlog +20% YoY. - SiPho tool revenue ramp. ### Milestones - 2026: Revenue +15% YoY. - 2027: SiPho share gain.
Browse all investment theses · Macro trends · Industries · Product categories